Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
1.32M
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
606K
-
Shares change
-
+243K
-
Total reported value, excl. options
-
$10.1M
-
Value change
-
+$4.04M
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$16.58
Significant Holders of PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (PIRS) as of Q3 2024
25 filings reported holding PIRS - PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value as of Q3 2024.
PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (PIRS) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 606K shares
of 1.32M outstanding shares and own 45.93% of the company stock.
Largest 10 shareholders include BVF INC/IL (258K shares), ADAR1 Capital Management, LLC (145K shares), BML Capital Management, LLC (42.1K shares), Lynx1 Capital Management LP (37.4K shares), RENAISSANCE TECHNOLOGIES LLC (32.2K shares), CM Management, LLC (22.5K shares), Frazier Life Sciences Management, L.P. (15.9K shares), BlackRock, Inc. (12.9K shares), GEODE CAPITAL MANAGEMENT, LLC (12K shares), and CITADEL ADVISORS LLC (11.7K shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.